Paracrine and autocrine regulation of epidermal growth factor-like factors in cumulus oocyte complexes and granulosa cells: Key roles for prostaglandin synthase 2 and progesterone receptor

Paracrine and autocrine regulation of epidermal growth factor-like factors in cumulus oocyte complexes and granulosa cells: Key roles for prostaglandin synthase 2 and progesterone receptor
复制标题

DOI:
10.1210/me.2005-0504
复制
发表时间:
2006-06-01
影响因子:
--
通讯作者:
Richards, JoAnne S.
Richards, JoAnne S.
中科院分区:
医学2区
文献类型:
--
作者:
Shimada, Masayuki;Hernandez-Gonzalez, Inmaculada;Richards, JoAnne S.

文献摘要

被引文献

相似文献

将促黄体生成素(LH)峰与几乎没有LH受体的卵丘细胞功能变化相联系的分子桥梁正在被揭示。在此我们证明,表皮生长因子(EGF)样因子双调蛋白(Areg)、上皮调节蛋白(Ereg)和β细胞素(Btc)通过涉及前列腺素(PGs)和孕激素受体(PGR)作用的自分泌和旁分泌机制在卵丘卵母细胞复合体(COCs)中被诱导。在人绒毛膜促性腺激素处理后4小时和8小时,分别从前列腺素合酶2(Ptgs2)基因敲除小鼠和孕激素受体基因敲除(PRKO)小鼠收集的COCs和卵巢中,Areg和Ereg的mRNA及蛋白质水平显著降低。在培养的COCs中,促卵泡激素(FSH)/毛喉素在0.5小时内诱导Areg mRNA,在4小时达到峰值,这一过程被p38丝裂原活化蛋白激酶(MAPK)抑制剂(SB203580)、MAPK激酶(MEK)1抑制剂(PD98059)和PTGS2抑制剂(NS398)阻断,但不被蛋白激酶A(PKA)抑制剂(KT5720)阻断。相反,AREG而非FSH在0.5小时诱导Ptsg2 mRNA,Ptgs2和Areg mRNA在4小时表达达到峰值,这些过程被表皮生长因子受体酪氨酸激酶抑制剂AG1478(AG)、PD98059和NS398阻断。PGE2逆转了AG对AREG诱导的Areg表达的抑制作用,但对Ptgs2无此作用,表明Ptgs2位于表皮生长因子受体(EGF - R)信号通路的下游。佛波醇12 - 肉豆蔻酸13 - 乙酸酯(PMA)和腺病毒表达的PGRA在颗粒细胞中协同诱导Areg mRNA。在COCs中,AREG不仅诱导影响基质形成的基因,还诱导参与类固醇生成(StAR,Cyp11a1)和免疫细胞样功能(Pdcd1,Runx1,Cd52)的基因。总之,FSH通过p38MAPK介导的Areg mRNA诱导先于AREG通过ERK1/2诱导的Ptgs2 mRNA。前列腺素通过卵丘细胞中的PTGER2发挥作用,为调节COCs中Areg的表达提供了一条次要的自分泌途径,显示了排卵卵泡中G蛋白偶联受体和生长因子受体通路之间的关键功能联系。
The molecular bridges that link the LH surge with functional changes in cumulus cells that possess few LH receptors are being unraveled. Herein we document that epidermal growth factor ( EGF)- like factors amphiregulin ( Areg), epiregulin ( Ereg), and betacellulin ( Btc) are induced in cumulus oocyte complexes ( COCs) by autocrine and paracrine mechanisms that involve the actions of prostaglandins ( PGs) and progesterone receptor ( PGR). Areg and Ereg mRNA and protein levels were reduced significantly in COCs and ovaries collected from prostaglandin synthase 2 ( Ptgs2) null mice and Pgr null ( PRKO) mice at 4 h and 8 h after human chorionic gonadotropin, respectively. In cultured COCs, FSH/forskolin induced Areg mRNA within 0.5 h that peaked at 4 h, a process blocked by inhibitors of p38MAPK ( SB203580), MAPK kinase (MEK) 1 ( PD98059), and PTGS2 ( NS398) but not protein kinase A ( PKA) ( KT5720). Conversely, AREG but not FSH induced Ptsg2 mRNA at 0.5 h with peak expression of Ptgs2 and Areg mRNAs at 4 h, processes blocked by the EGF receptor tyrosine kinase inhibitor AG1478 ( AG), PD98059, and NS398. PGE2 reversed the inhibitory effects of AG on AREG-induced expression of Areg but not Ptgs2, placing Ptgs2 downstream of EGF-R signaling. Phorbol 12- myristate 13-acetate (PMA) and adenovirally expressed PGRA synergistically induced Areg mRNA in granulosa cells. In COCs, AREG not only induced genes that impact matrix formation but also genes involved in steroidogenesis ( StAR, Cyp11a1) and immune cell-like functions (Pdcd1, Runx1, Cd52). Collectively, FSH-mediated induction of Areg mRNA via p38MAPK precedes AREG induction of Ptgs2 mRNA via ERK1/2. PGs acting via PTGER2 in cumulus cells provide a secondary, autocrine pathway to regulate expression of Areg in COCs showing critical functional links between G protein- coupled receptor and growth factor receptor pathways in ovulating follicles.